Author: oncologs.com

HOUSTON ― The James P. Allison Institute at The University of Texas MD Anderson Cancer Center today announced the appointment of its newest members, Susan Bullman, Ph.D., and Xi Chen, Ph.D., to further the institute’s ongoing work of impactful immunobiology research. These accomplished researchers, joining

The Focused Ultrasound Foundation has designated Virginia Tech as a Focused Ultrasound (FUS) Center of Excellence, making it the sixth such center in the United States and one of only 12 in the world. Credit: Clayton Metz/Virginia Tech The Focused Ultrasound Foundation has designated Virginia

UCLA scientists have identified a protein that plays a critical role in regulating human blood stem cell self-renewal by helping them sense and interpret signals from their environment. Credit: Tiare Dunlap | UCLA Broad Stem Cell Research Center UCLA scientists have identified a protein that

Some children with autism experience profound, lifelong difficulties like developmental delay, social struggles and even the inability to speak. Others experience more mild symptoms that improve with time. Credit: UC San Diego Health Sciences Some children with autism experience profound, lifelong difficulties like developmental delay,

Pioneers in transformative research with clinical applications will discuss how space is advancing discoveries within the biomedical community at the 13th annual International Space Station Research and Development Conference (ISSRDC). The session “Trailblazing New Frontiers in Science on the Space Station” will provide insights into recent breakthroughs in

OKLAHOMA CITY, OKLA. – With a $1.2 million grant to the University of Oklahoma, an OU Health urologic oncologist is leading an innovative new clinical trial for the treatment of prostate cancer when the cancer is beginning to spread beyond the prostate. The trial, offered

A group of researchers at University of California San Diego has identified the cause of a “short-circuit” in cellular pathways, a discovery that sheds new light on the genesis of a number of human diseases. Credit: UC San Diego Health Sciences A group of researchers

Immunotherapy is based on harnessing a person’s own immune system to attack cancer cells. However, patients with certain tumors do not respond to these therapies and it remains unclear why. Credit: Kevin Tharp, Sanford Burnham Prebys Immunotherapy is based on harnessing a person’s own immune

The length of telomeres that protect the ends of our chromosomes should be tightly regulated. Those that are too long predispose to cancer, and those that are too short lose their protective ability, resulting in telomere disorders with serious health consequences. Our cells prevent this

“[…] due to the general lack of robust predictive biomarkers, a standardized risk stratification tool is not utilized in clinical practice – a prime area for research.” Credit: 2024 Patel et al. “[…] due to the general lack of robust predictive biomarkers, a standardized risk